ANDA 70545, held by Hikma. Bretylium Tosylate.
As of Nov 16, 2026, ANDA 70545 (Bretylium Tosylate), held by Hikma, was first approved by FDA on May 14, 1986, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 14, 1986 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Bretylium Tosylate50MG/ML ยท injectable;injection | Bretylium Tosylate | Discontinued |
| Jun 22, 1994 | Supplement 6Labeling | Approved | None posted |
| Apr 9, 1990 | Supplement 4Labeling | Approved | None posted |
| Apr 3, 1990 | Supplement 5Manufacturing | Approved | None posted |
| Jan 24, 1989 | Supplement 3Manufacturing | Approved | None posted |
| Nov 3, 1986 | Supplement 2Manufacturing | Approved | None posted |
| Jun 4, 1986 | Supplement 1Labeling | Approved | None posted |
| May 14, 1986 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters